Center for Health Equity Research and Promotion

Profile

Thomas R. Radomski, MD, MS, is CHERP COIN investigator and Associate Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh, where he is also a Core Faculty member at the Center for Pharmaceutical Policy and Prescribing.

As a practicing general internist and health services researcher, Dr. Radomski has dedicated his career to improving the quality, safety, and value of Veteran’s healthcare by developing and implementing patient-centered approaches to identify and reduce health service overuse. He has been funded by NIH and VA grants to develop, validate, and apply a metric of low-value prescribing in older adults and evaluate the use and cost of low-value health services by Veterans in VA and non-VA care settings. His research has been published in journals such as JAMA, JAMA Internal Medicine, and the Annals of Internal Medicine, and he is the recipient of several awards for research and patient care, including the Award for Excellent in Clinician Investigation from the Society of General Internal Medicine Mid-Atlantic Region, Distinguished Alumnus Award in Clinical Research from Pitt’s Institute for Clinical Research Education, and was named a Top Physician Under 40 by the Pennsylvania Medical Society.

Dr. Radomski is also passionate about training the next generation of leaders in clinical and translational science. He is the Associate Director of the University of Pittsburgh’s Institute for Clinical Research Education and Directs their Graduate Programs in Clinical and Translational Science. He also serves as MPI and Director of Pitt’s the Post-Doctoral Clinical and Translational Science Fellowship (TL1).

Apart from his research, Dr. Radomski maintains an active outpatient General Internal Medicine practice and supervises residents and medical students on the inpatient general medicine wards. He is also active within the Society of General Internal Medicine (SGIM), where he serves on the National Council as Chair of the Board of Regional Leaders and as co-chair of the 2025 National SGIM Meeting.